Kevin G. DaSilva
Currently, Kevin G. DaSilva is Treasurer & Vice President for Raytheon Technologies Corp. and Treasurer at Raytheon International, Inc. (a subsidiary of Raytheon Technologies Corp.). He is also on the board of VNUS Medical Technologies, Inc. and Dana-Farber Cancer Institute, Inc.
Kevin G. DaSilva previously occupied the position of VP-Finance & CFO-Worldwide Services Division at Lucent Technologies, Inc., Treasurer & Vice President for Tyco International Ltd., Group CFO-Development Markets & Vice President at Covidien Unlimited Co., Vice President-Treasury at Raytheon Co., Treasurer, Director & Vice President at United States Surgical Corp., Treasurer, Director & Vice President at ev3, Inc. and Group Chief Financial Officer, Treasurer & VP at Covidien Holding, Inc.
Kevin G. DaSilva received an undergraduate degree from Georgetown University and a graduate degree from Kellogg School of Management.
Transactions
| 03/25/2022 | 692 | Derivative/Non-derivative trans. at $102.43 per share. | 70,882 |
| 03/21/2022 | 566 | Derivative/Non-derivative trans. at $99.94 per share. | 56,567 |
| 03/21/2022 | 384 | Derivative/Non-derivative trans. at $99.94 per share. | 38,377 |
| 01/31/2022 | 2,050 | Derivative/Non-derivative trans. at $90.19 per share. | 184,890 |
| 01/30/2022 | 6,787 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 03/22/2021 | 375 | Derivative/Non-derivative trans. at $76.92 per share. | 28,845 |
| 03/22/2021 | 368 | Derivative/Non-derivative trans. at $76.92 per share. | 28,307 |
| 01/25/2021 | 2,050 | Derivative/Non-derivative trans. at $66.28 per share. | 135,874 |
| 01/24/2021 | 6,673 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 04/03/2020 | 796 | Derivative/Non-derivative trans. at $49.93 per share. | 39,745 |
| 04/03/2020 | 38,381 | Award at $0 per share. | 0 |
